Immediate Impact
1 from Science/Nature 68 standout
Citing Papers
The Women’s Health Initiative Randomized Trials and Clinical Practice
2024 Standout
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
Works of D. Rea being referenced
A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer
2005
Metastatic breast cancer response after Exemestane withdrawal: a case report
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| D. Rea | 152 | 48 | 92 | 75 | 21 | 308 | |
| Hiroyuki Hachiya | 149 | 48 | 57 | 34 | 25 | 309 | |
| I.M. Nilsson | 92 | 98 | 49 | 121 | 20 | 363 | |
| Yilu Feng | 92 | 102 | 67 | 12 | 19 | 349 | |
| Yi–Dan Yan | 57 | 22 | 44 | 34 | 42 | 369 | |
| Vidar G. Flote | 180 | 104 | 78 | 44 | 22 | 358 | |
| Sunamchok Srijaipracharoen | 219 | 76 | 35 | 19 | 20 | 357 | |
| Pascale Missy | 140 | 56 | 181 | 54 | 22 | 333 | |
| İsmail Savaş | 53 | 53 | 91 | 8 | 34 | 304 | |
| C.M. Lalanne | 101 | 81 | 47 | 100 | 26 | 329 | |
| Terumi Mizuno | 82 | 55 | 48 | 35 | 14 | 356 |
All Works
Loading papers...